Goldman Sachs’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $165K | Sell |
|
|||||
|
2023
Q1 | $424K | Sell |
|
|||||
|
2022
Q4 | $387K | Hold |
|
|||||
|
2022
Q3 | $397K | Hold |
|
|||||
|
2022
Q2 | $495K | Hold |
|
|||||
|
2022
Q1 | $907K | Hold |
|
|||||
|
2021
Q4 | $900K | Sell |
|
|||||
|
2021
Q3 | $1.64M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2021
Q1 | $3.99M | Buy |
|
|||||
|
2020
Q4 | $2.92M | Sell |
|
|||||
|
2020
Q3 | $4.2M | Buy |
|
|||||
|
2020
Q2 | $4.27M | Sell |
|
|||||
|
2020
Q1 | $4.04M | Buy |
|
|||||
|
2019
Q4 | $160K | Buy |
|